Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing BARCLAYS PLC
(Note 1)
Company dealt in INVERNESS MEDICAL INNOVATIONS INC
Class of relevant security COM STK USD0.001
to which the dealings being
disclosed relate (Note 2)
Date of dealing 12 February 2008
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant 2,424,471 3.15% 59,858 0.08%
securities
(2) Derivatives 0 0.00% 0 0.00%
(other than
options)
(3) Options and 0 0.00% 0 0.00%
agreements to
purchase/sell
Total 2,424,471 3.15% 59,858 0.08%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of Long Short
relevant
security:
Number (%) Number (%)
(1) Relevant
securities
(2) Derivatives
(other than
options)
(3) Options and
agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of Securities Price per unit
(GBP)
Purchase 243 44.8760 USD
Purchase 560 44.8760 USD
Purchase 2,809 44.8760 USD
Purchase 12,120 44.6400 USD
Purchase 165 44.8760 USD
Purchase 341 44.8643 USD
Purchase 825 44.6400 USD
Purchase 11,716 44.6400 USD
Purchase 8,080 44.6400 USD
Purchase 338 45.2300 USD
Purchase 8,080 44.6400 USD
Purchase 12,120 44.6400 USD
Purchase 700 44.8893 USD
Purchase 85 44.8760 USD
Purchase 4,059 44.8643 USD
Purchase 1,023 44.8760 USD
Purchase 16,160 44.6400 USD
Sale 7,070 44.6400 USD
Sale 1,215 44.6400 USD
Sale 249 44.6417 USD
Sale 1,458 44.6400 USD
(b) Derivatives transactions (other than options)
Product name, Long/Short Number of Price per
(e.g. CFD) (Note 6) Securities unit (GBP)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call selling, securities to price American, date paid/received
option purchasing, which the option European etc. per unit (GBP)
varying etc. relates (GBP)
(ii) Exercising
Product name, e.g. Number of Exercise price per
call option securities unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
4. OTHER INFORMATION
None
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of
any relevant securities under any option referred to on this form or
relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 13 February 2008
Contact name Geoff Smith
Telephone number 020 7116 2913
If a connected EFM, name of
offeree/offeror with which connected
If a connected EFM, state nature of
connection (Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk